BAppSci GradCertBus - 4DMedical Ex Director

All Insiders . USA . 
Stock . 4DMedical Limited . Stakeholders . Insider . BAppSci GradCertBus
FDMDF Stock  USD 2.35  0.50  27.03%   

Insider

BAppSci GradCertBus is Ex Director of 4DMedical Limited
Phone61 3 9545 5940
Webhttps://www.4dmedical.com

4DMedical Management Efficiency

The company has return on total asset (ROA) of (0.2752) % which means that it has lost $0.2752 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3443) %, meaning that it generated substantial loss on money invested by shareholders. 4DMedical's management efficiency ratios could be used to measure how well 4DMedical manages its routine affairs as well as how well it operates its assets and liabilities.
4DMedical Limited has accumulated 1.3 M in total debt with debt to equity ratio (D/E) of 0.02, which may suggest the company is not taking enough advantage from borrowing. 4DMedical Limited has a current ratio of 12.67, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist 4DMedical until it has trouble settling it off, either with new capital or with free cash flow. So, 4DMedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like 4DMedical Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for 4DMedical to invest in growth at high rates of return. When we think about 4DMedical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Kazuhiko YoshizumiSosei Group
69
Yve ThorenburgCellaVision AB
65
Chris CargillSosei Group
39
Matthew HeathAllergy Therapeutics plc
N/A
Tim MoorePolyNovo Limited
N/A
Santiago PuigAllergy Therapeutics plc
N/A
MBA BPHARMPolyNovo Limited
N/A
Prof CepkoGenSight Biologics SA
N/A
Miles CongreveSosei Group
N/A
JoseAlain MDGenSight Biologics SA
N/A
Kristoffer NordstromXvivo Perfusion AB
38
Russell PicketAllergy Therapeutics plc
N/A
Clothilde CailletGenSight Biologics SA
N/A
Hironoshin NomuraSosei Group
N/A
Barry KennySosei Group
N/A
Teena ChadhaPolyNovo Limited
N/A
Stacey SouthallSosei Group
N/A
Shinichiro NishishitaSosei Group
N/A
Beverly LeesAllergy Therapeutics plc
N/A
Murray SkinnerAllergy Therapeutics plc
N/A
Ahmed HassanPolyNovo Limited
N/A
4DMedical Limited operates as a medical technology company in Australia and the United States. The company was incorporated in 2012 and is based in Carlton, Australia. 4Dmedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 95 people. 4DMedical Limited [FDMDF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Return On Equity-0.34
Return On Asset-0.28

4DMedical Limited Leadership Team

Elected by the shareholders, the 4DMedical's board of directors comprises two types of representatives: 4DMedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 4DMedical. The board's role is to monitor 4DMedical's management team and ensure that shareholders' interests are well served. 4DMedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 4DMedical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Beth Plunkett, Company Counsel
Aidan BE, VP Engineering
Michael Curtis, Chief Architect
Clint Rodgers, VP Communications
Rachael Tenkaten, Chief Staff
BAppSci GradCertBus, Ex Director
Andreas MAICD, MD, Founder
Simon Glover, Chief Officer
Paul BA, Sr Devel

4DMedical Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is 4DMedical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.34
Return On Asset-0.28
Operating Margin(34.86) %
Current Valuation55.4 M
Shares Outstanding294.49 M
Shares Owned By Insiders35.16 %
Shares Owned By Institutions10.35 %
Price To Book2.69 X
Price To Sales102.71 X
Revenue1.05 M

Currently Active Assets on Macroaxis

DDDupont De Nemours
CRDOCredo Technology Group
GOOGAlphabet Inc Class C
BACBank of America
CRMSalesforce

Other Information on Investing in 4DMedical Pink Sheet

4DMedical financial ratios help investors to determine whether 4DMedical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 4DMedical with respect to the benefits of owning 4DMedical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY